Received Mar 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 49TM3 | — |
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
booster was not administered; received on 15-SEP-2021; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old female patient who received DTPa (Infanrix) for prophylaxis. Co-suspect products included DTPa (Infanrix) (batch number 49TM3, expiry date 28-MAY-2022) for prophylaxis. Concurrent medical conditions included immunocompromised and multiple allergies. On an unknown date, the patient did not received the 2nd dose of Infanrix. On 15-SEP-2021, the patient received the 1st dose of Infanrix. On 15-SEP-2021, not applicable after receiving Infanrix and an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: received on 15-SEP-2021). On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: booster was not administered). The outcome of the inappropriate age at vaccine administration and incomplete course of vaccination were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-MAR-2025 The nurse reported that a patient who was in here for her well check and she was immunocompromised and allergies had drawn titers and recommended she had have another DTAP, now she was out of the age range and asked for provided multiple times if this was the vaccine that we should give and they said yes but they just wanted to make sure that this would, that she was still within the parameters for that vaccine. The health care professional confirmed that the patient completed the Infanrix schedule. The heath care professional did not have dates or lot numbers of all the vaccines administered but provided the first one administered on September 15th, 2021. Patient was immunocompromised and the booster was not administered. Till the time of reporting, the patient did not receive 2nd dose of Infanrix, which led to incomplete course of vaccination. The patient received a dose of Infanrix at an inappropriate age, which led to inappropriate age at vaccine administration.
Immunocompromised; Multiple allergies